Tumor immunotherapy exerts its anti-tumor effects by stimulating and enhancing immune
responses of the body. It has become another important modality of anti-tumor therapy with …

Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Immunogenic cell death (ICD) can activate the anticancer immune response and is highly
attractive to improve cancer treatment efficacy. ICD is closely related to endoplasmic …

The efficacy of standard glioblastoma (GBM) treatments has been limited due to the highly
immunosuppressive tumor immune microenvironment, interpatient tumor heterogenicity and …

Programmed cell death (PCD, mainly including apoptosis, necrosis, ferroptosis, pyroptosis,
and autophagy) and immunogenic cell death (ICD), as important cell death mechanisms, are …

Although nano-immunotherapy has advanced dramatically in recent times, there remain two
significant hurdles related to immune systems in cancer treatment, such as (namely) …

Breast carcinoma is a molecularly diverse illness, and it is among the most prominent and
often reported malignancies in female across the globe. Surgical intervention …

Immunotherapy exerts its excellent anti-tumor effects by stimulating and enhancing the
immune response of the body, and has become another important class of anti-tumor …

Low immunogenicity and immunosuppressive tumor microenvironments are major hurdles
in the application of cancer immunotherapy. To date, several immunogenic cell death (ICD) …

The recent decade has witnessed a remarkable surge in the field of nanoparticles, from their
synthesis, characterization, and functionalization to diverse applications. At the nanoscale …